Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000645735 | SCV000767489 | benign | Intellectual disability, autosomal dominant 5 | 2023-03-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317404 | SCV000851217 | uncertain significance | Inborn genetic diseases | 2016-09-01 | criteria provided, single submitter | clinical testing | The p.V866I variant (also known as c.2596G>A), located in coding exon 15 of the SYNGAP1 gene, results from a G to A substitution at nucleotide position 2596. The valine at codon 866 is replaced by isoleucine, an amino acid with highly similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
New York Genome Center | RCV000645735 | SCV001815738 | uncertain significance | Intellectual disability, autosomal dominant 5 | 2020-11-12 | criteria provided, single submitter | clinical testing |